The metabolic cost of lowering blood pressure with hydrochlorothiazide.

Price, Angela L; Lingvay, Ildiko; Szczepaniak, Edward W; Wiebel, Jaime; Victor, Ronald G; Szczepaniak, Lidia S

Price, Angela L; Lingvay, Ildiko; Szczepaniak, Edward W; Wiebel, Jaime; Victor, Ronald G; Szczepaniak, Lidia S.

Afiliação

Price AL; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Lingvay I; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Szczepaniak EW; Cedars -Sinai Medical Center, The Heart Institute, Los Angeles, California, USA.
Wiebel J; Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas, USA.
Victor RG; Cedars -Sinai Medical Center, The Heart Institute, Los Angeles, California, USA.
Szczepaniak LS; Cedars -Sinai Medical Center, The Heart Institute, Los Angeles, California, USA.

Diabetol Metab Syndr ; 5(1): 35, 2013 Jul 09.

Article em En | MEDLINE | ID: mdl-23837919

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Health_economic_evaluation Idioma: En Revista: Diabetol Metab Syndr Ano de publicação: 2013 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google